T-cell lymphoblastic lymphoma involving the ocular adnexa: report of two cases and review of the current literature

References

• Jakobiec FA. Ocular adnexal lymphoid tumors: progress in need of clarification. Am J Ophthalmol. 2008;145(6):941–950. doi:10.1016/j.ajo.2008.03.013.
   PubMed Web of Science ®Google Scholar
• Ferry JA, Fung CY, Zukerberg L, et al. Lymphoma of the ocular adnexa: A study of 353 cases. Am J Surg Pathol. 2007;31(2):170–184. doi:10.1097/01.pas.0000213350.49767.46.
   PubMed Web of Science ®Google Scholar
• Briscoe D, Safieh C, Ton Y, Shapiro H, Assia EI, Kidron D. Characteristics of orbital lymphoma: a clinicopathological study of 26 cases. Int Ophthalmol. 2017. doi:10.1007/s10792-017-0457-y.
   PubMed Web of Science ®Google Scholar
• Burkhardt B, Mueller S, Khanam T, Perkins SL. Current status and future directions of T-lymphoblastic lymphoma in children and adolescents. Br J Haematol. 2016;173(4):545–559. doi:10.1111/bjh.14017.
   PubMed Web of Science ®Google Scholar
• Cortelazzo S, Ferreri A, Hoelzer D, Ponzoni M. Lymphoblastic lymphoma. Crit Rev Oncol Hematol. 2017;113:304–317. doi:10.1016/j.critrevonc.2017.03.020.
   PubMed Web of Science ®Google Scholar
• You MJ, Medeiros LJ, Hsi ED. T-lymphoblastic leukemia/lymphoma. Am J Clin Pathol. 2015;144(3):411–422. doi:10.1309/AJCPMF03LVSBLHPJ.
   PubMed Web of Science ®Google Scholar
• El-Fattah MA. Prognostic Factors and. Outcomes of adult lymphoblastic lymphoma in the United States. Clin Lymphoma Myeloma Leuk. 2017;17(8):498–505. e496. doi:10.1016/j.clml.2017.05.016.
   PubMed Web of Science ®Google Scholar
• Ryu IH, Cho IS, Ryu AJ, et al. Long-term survival after T-cell lymphoblastic lymphoma treated with one cycle of hyper-CVAD regimen. Cancer Res Treat. 2015;47(1):115–119. doi:10.4143/crt.2013.122.
   PubMed Web of Science ®Google Scholar
• Leidenix MJ, Mamalis N, Olson RJ, McLeish WM, Anderson RL. Primary T-cell immunoblastic lymphoma of the orbit in a pediatric patient. Ophthalmology. 1993;100:998–1002.
   PubMed Web of Science ®Google Scholar
• Stenman L, Persson M, Enlund F, Clasen-Linde E, Stenman G, Heegaard S. Primary orbital precursor T-cell lymphoblastic lymphoma: report of a unique case. Mol Clin Oncol. 2016;5(5):593–595. doi:10.3892/mco.2016.1008.
   PubMed Web of Science ®Google Scholar
• Wadhwani M, Verma D, Agarwal K, Prakash O, Shukla S. T-cell lymphoblastic lymphoma of Tenon’s capsule: an unusual presentation. Int Ophthalmol. 2014;34(3):639–642. doi:10.1007/s10792-013-9832-5.
   PubMed Web of Science ®Google Scholar
• Chen TH, Farooq AV, Shah HA. Pediatric patient with T-cell lymphoblastic lymphoma and acute vision loss. JAMA Ophthalmol. 2018;136(2):213–214. doi:10.1001/jamaophthalmol.2017.4003.
   PubMed Web of Science ®Google Scholar
• Hon C, Au WY, Ma ES, Kwok AK, Lie AK, Liang RH. Unusual sites of involvement in non-Hodgkin’s lymphoma: case 1. Isolated orbit relapse after allogeneic bone marrow transplantation for malignant lymphoma. J Clin Oncol. 2002;20(21):4394–4395. doi:10.1200/JCO.2002.20.21.4394.
   PubMed Web of Science ®Google Scholar
• Abdelouahed K, Laghmari M, Tachfouti S, et al. [T-cell acute lymphoblastic leukemia/orbital lymphoblastic lymphoma in children]. J Fr Ophtalmol. 2005;28(2):197–200.
   PubMed Web of Science ®Google Scholar
• Esmaeli B, Medeiros LJ, Myers J, Champlin R, Singh S, Ginsberg L. Orbital mass secondary to precursor T-cell acute lymphoblastic leukemia: a rare presentation. Archives of Ophthalmology (Chicago, Ill: 1960). 2001;119:443–446.
   PubMedGoogle Scholar
• Terada T. TDT (-), KIT (+), CD34 (+), CD99 (+) precursor T lymphoblastic leukemia/lymphoma. Int J Clin Exp Pathol. 2012;5:167–170.
   PubMed Web of Science ®Google Scholar
• Jain N, Lamb AV, O’Brien S, et al. Early T-cell precursor acute lymphoblastic leukemia/lymphoma (ETP-ALL/LBL) in adolescents and adults: a high-risk subtype. Blood. 2016;127(15):1863–1869. doi:10.1182/blood-2015-08-661702.
   PubMed Web of Science ®Google Scholar
• Hoelzer D, Gokbuget N, Digel W, et al. Outcome of adult patients with T-lymphoblastic lymphoma treated according to protocols for acute lymphoblastic leukemia. Blood. 2002;99(12):4379–4385. doi:10.1182/blood-2002-01-0110.
   PubMed Web of Science ®Google Scholar
• Reiter A, Schrappe M, Ludwig WD, et al. Intensive ALL-type therapy without local radiotherapy provides a 90% event-free survival for children with T-cell lymphoblastic lymphoma: a BFM group report. Blood. 2000;95(2):416–421.
   PubMed Web of Science ®Google Scholar
• Baro J, Richard C, Sierra J, et al. Autologous bone marrow transplantation in 22 adult patients with lymphoblastic lymphoma responsive to conventional dose chemotherapy. Bone Marrow Transplant. 1992;10(1):33–38.
   PubMed Web of Science ®Google Scholar
• Zinzani PL, Bendandi M, Visani G, et al. Adult lymphoblastic lymphoma: clinical features and prognostic factors in 53 patients. Leuk Lymphoma. 1996;23(5–6):577–582. doi:10.3109/10428199609054867.
   PubMed Web of Science ®Google Scholar
• Thomas DA, O’Brien S, Cortes J, et al. Outcome with the hyper-CVAD regimens in lymphoblastic lymphoma. Blood. 2004;104(6):1624–1630. doi:10.1182/blood-2003-12-4428.
   PubMed Web of Science ®Google Scholar
• Uyttebroeck A, Suciu S, Laureys G, et al. Treatment of childhood T-cell lymphoblastic lymphoma according to the strategy for acute lymphoblastic leukaemia, without radiotherapy: long term results of the EORTC CLG 58881 trial. Eur J Cancer. 2008;44(6):840–846. doi:10.1016/j.ejca.2008.02.011.
   PubMed Web of Science ®Google Scholar
• Sandlund JT, Pui CH, Zhou Y, et al. Effective treatment of advanced-stage childhood lymphoblastic lymphoma without prophylactic cranial irradiation: results of St Jude NHL13 study. Leukemia. 2009;23(6):1127–1130. doi:10.1038/leu.2008.400.
   PubMed Web of Science ®Google Scholar
• Termuhlen AM, Smith LM, Perkins SL, et al. Disseminated lymphoblastic lymphoma in children and adolescents: results of the COG A5971 trial: a report from the Children’s Oncology Group. Br J Haematol. 2013;162(6):792–801. doi:10.1111/bjh.12460.
   PubMed Web of Science ®Google Scholar
• Attarbaschi A, Mann G, Dworzak M, Wiesbauer P, Schrappe M, Gadner H. Mediastinal mass in childhood T-cell acute lymphoblastic leukemia: significance and therapy response. Med Pediatr Oncol. 2002;39(6):558–565. doi:10.1002/mpo.10164.
   PubMedGoogle Scholar
• Murphy SB, Hustu HO. A randomized trial of combined modality therapy of childhood non-Hodgkin’s lymphoma. Cancer. 1980;45:630–637.
   PubMed Web of Science ®Google Scholar
• Burkhardt B, Reiter A, Landmann E, et al. Poor outcome for children and adolescents with progressive disease or relapse of lymphoblastic lymphoma: a report from the berlin-frankfurt-muenster group. J Clin Oncol. 2009;27(20):3363–3369. doi:10.1200/JCO.2008.19.3367.
   PubMed Web of Science ®Google Scholar
• Gokbuget N, Basara N, Baurmann H, et al. High single-drug activity of nelarabine in relapsed T-lymphoblastic leukemia/lymphoma offers curative option with subsequent stem cell transplantation. Blood. 2011;118(13):3504–3511. doi:10.1182/blood-2011-01-329441.
   PubMed Web of Science ®Google Scholar
• DeAngelo DJ, Yu D, Johnson JL, et al. Nelarabine induces complete remissions in adults with relapsed or refractory T-lineage acute lymphoblastic leukemia or lymphoblastic lymphoma: cancer and Leukemia Group B study 19801. Blood. 2007;109(12):5136–5142. doi:10.1182/blood-2006-11-056754.
   PubMed Web of Science ®Google Scholar